Changes in the proportion of clinical clusters contribute to the phenotypic evolution of Behçet's disease in Japan
BACKGROUND: We hypothesized that Behçet's disease (BD) consists of several clinical subtypes with different severity, resulting in heterogeneity of the disease. Here, we conducted a study to identify clinical clusters of BD.
METHODS: A total of 657 patients registered in the Yokohama City University (YCU) regional BD registry between 1990 and 2018, as well as 6754 patients who were initially registered in the Japanese Ministry of Health, Labour and Welfare (MHLW) database between 2003 and 2014, were investigated. The YCU registry data regarding the clinical manifestations of BD, human leukocyte antigen (HLA) status, treatments, and hospitalizations were analyzed first, followed by similar analyses of the MHLW for validation. A hierarchical cluster analysis was independently performed in both patient groups.
RESULTS: A hierarchical cluster analysis determined five independent clinical clusters in the YCU cohort. Individual counterparts of the YCU clusters were confirmed in the MHLW registry. Recent phenotypical evolutions of BD in Japan, such as increased gastrointestinal (GI) involvement, reduced complete type according to the Japan Criteria, and reduced HLA-B51 positivity were associated with chronologically changing proportions of the clinical clusters.
CONCLUSIONS: In this study, we identified independent clinical clusters among BD patients in Japan and found that the proportion of each cluster varied over time. We propose five independent clusters namely "mucocutaneous", "mucocutaneous with arthritis", "neuro", "GI", and "eye.".
| Errataetall: |
CommentIn: Nat Rev Rheumatol. 2021 Apr;17(4):188. - PMID 33619366 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:23 |
|---|---|
| Enthalten in: |
Arthritis research & therapy - 23(2021), 1 vom: 01. Feb., Seite 49 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Soejima, Yutaro [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Behçet’s disease |
|---|
| Anmerkungen: |
Date Completed 21.06.2021 Date Revised 21.06.2021 published: Electronic CommentIn: Nat Rev Rheumatol. 2021 Apr;17(4):188. - PMID 33619366 Citation Status MEDLINE |
|---|
| doi: |
10.1186/s13075-020-02406-6 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM320840891 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM320840891 | ||
| 003 | DE-627 | ||
| 005 | 20231225174510.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s13075-020-02406-6 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1069.xml |
| 035 | |a (DE-627)NLM320840891 | ||
| 035 | |a (NLM)33522943 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Soejima, Yutaro |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Changes in the proportion of clinical clusters contribute to the phenotypic evolution of Behçet's disease in Japan |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 21.06.2021 | ||
| 500 | |a Date Revised 21.06.2021 | ||
| 500 | |a published: Electronic | ||
| 500 | |a CommentIn: Nat Rev Rheumatol. 2021 Apr;17(4):188. - PMID 33619366 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a BACKGROUND: We hypothesized that Behçet's disease (BD) consists of several clinical subtypes with different severity, resulting in heterogeneity of the disease. Here, we conducted a study to identify clinical clusters of BD | ||
| 520 | |a METHODS: A total of 657 patients registered in the Yokohama City University (YCU) regional BD registry between 1990 and 2018, as well as 6754 patients who were initially registered in the Japanese Ministry of Health, Labour and Welfare (MHLW) database between 2003 and 2014, were investigated. The YCU registry data regarding the clinical manifestations of BD, human leukocyte antigen (HLA) status, treatments, and hospitalizations were analyzed first, followed by similar analyses of the MHLW for validation. A hierarchical cluster analysis was independently performed in both patient groups | ||
| 520 | |a RESULTS: A hierarchical cluster analysis determined five independent clinical clusters in the YCU cohort. Individual counterparts of the YCU clusters were confirmed in the MHLW registry. Recent phenotypical evolutions of BD in Japan, such as increased gastrointestinal (GI) involvement, reduced complete type according to the Japan Criteria, and reduced HLA-B51 positivity were associated with chronologically changing proportions of the clinical clusters | ||
| 520 | |a CONCLUSIONS: In this study, we identified independent clinical clusters among BD patients in Japan and found that the proportion of each cluster varied over time. We propose five independent clusters namely "mucocutaneous", "mucocutaneous with arthritis", "neuro", "GI", and "eye." | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Behçet’s disease | |
| 650 | 4 | |a Cluster analysis | |
| 650 | 4 | |a Intestinal manifestation | |
| 650 | 7 | |a HLA-B Antigens |2 NLM | |
| 650 | 7 | |a HLA-B51 Antigen |2 NLM | |
| 700 | 1 | |a Kirino, Yohei |e verfasserin |4 aut | |
| 700 | 1 | |a Takeno, Mitsuhiro |e verfasserin |4 aut | |
| 700 | 1 | |a Kurosawa, Michiko |e verfasserin |4 aut | |
| 700 | 1 | |a Takeuchi, Masaki |e verfasserin |4 aut | |
| 700 | 1 | |a Yoshimi, Ryusuke |e verfasserin |4 aut | |
| 700 | 1 | |a Sugiyama, Yumiko |e verfasserin |4 aut | |
| 700 | 1 | |a Ohno, Shigeru |e verfasserin |4 aut | |
| 700 | 1 | |a Asami, Yukiko |e verfasserin |4 aut | |
| 700 | 1 | |a Sekiguchi, Akiko |e verfasserin |4 aut | |
| 700 | 1 | |a Igarashi, Toshihisa |e verfasserin |4 aut | |
| 700 | 1 | |a Nagaoka, Shohei |e verfasserin |4 aut | |
| 700 | 1 | |a Ishigatsubo, Yoshiaki |e verfasserin |4 aut | |
| 700 | 1 | |a Nakajima, Hideaki |e verfasserin |4 aut | |
| 700 | 1 | |a Mizuki, Nobuhisa |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Arthritis research & therapy |d 2003 |g 23(2021), 1 vom: 01. Feb., Seite 49 |w (DE-627)NLM124870457 |x 1478-6362 |7 nnns |
| 773 | 1 | 8 | |g volume:23 |g year:2021 |g number:1 |g day:01 |g month:02 |g pages:49 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1186/s13075-020-02406-6 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 23 |j 2021 |e 1 |b 01 |c 02 |h 49 | ||